Valeant Extends Tender Offer for Allergan

Aug. 15 (Bloomberg) -- Valeant Pharmaceuticals said it extended its offer to purchase Allergan until the end of the year, after an initial deadline for its tender offer was scheduled to expire today. Pimm Fox reports on "Taking Stock." (Source: Bloomberg)
Who Are the Authors Publishing Houses Rely On?
47:18 - Bloomberg's David Gura reports on book publishing and Author Stephen King's enduring success. He speaks on “Bloomberg Markets.” (Source: Bloomberg)
  • Fitbit Looks to Raise $478 Million in IPO
  • Human Error Not Ruled Out in Amtrak Crash
  • Dow Lower: Energy Leads, Utilities Lag